HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chang-Hua Hu Selected Research

Histamine Agonists

10/2015Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Chang-Hua Hu Research Topics

Disease

2Dyslipidemias (Dyslipidemia)
10/2015 - 05/2015
2Infection
03/2004 - 02/2003
1Weight Gain
10/2015
1Schizophrenia (Dementia Praecox)
02/2015
1Contagious Ecthyma (Orf)
11/2010
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2005
1Anoxia (Hypoxia)
03/2004

Drug/Important Bio-Agent (IBA)

3Antipsychotic Agents (Antipsychotics)IBA
10/2015 - 02/2015
2olanzapine (Zyprexa)FDA Link
10/2015 - 05/2015
1Betahistine (Serc)IBA
10/2015
1Carbon MonoxideIBA
10/2015
1Histamine AgonistsIBA
10/2015
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
10/2015
1Neuregulin-1 (Neuregulin 1)IBA
02/2015
1Amino AcidsFDA Link
11/2010
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
03/2004
1butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)IBA
03/2004
1Toll-Like Receptor 2IBA
03/2004
1Calcitriol Receptors (Calcitriol Receptor)IBA
03/2004
1Serine Proteases (Serine Protease)IBA
03/2004
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
03/2004
1DNA (Deoxyribonucleic Acid)IBA
03/2004
1Ion Channels (Ion Channel)IBA
02/2003

Therapy/Procedure

1Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2005